Track the 인트론바이오 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 인트론바이오 has published 1 insider filings. Market capitalisation: €78.6bn. The latest transaction was disclosed on 4 March 2026 (Other). Among the most active insiders: 인트론바이오. All data is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.